CURRICULUM VITAE Ajay Sahai BHATNAGAR Personal History:
Date of Birth:
Citizenship: Switzerland Marital Status:
Education and Degrees:
1963-1967
University of Basel, Switzerland, Ph.D.
University of Cambridge, England, M.A.
University of Cambridge, England B.A. (Hons.) Postdoctoral Training:
1968-1970
Council of Scientific and Industrial Research
For more information and interaction contact
Advanced Strategies Pvt. Ltd. http://www.astrategies.com info@astrategies.com +91-22-22672561
Current and Academic Appointments:
2001 to date
Head, Global Business Continuity Planning
Novartis Pharma AG, CH-4002 Basel, Switzerland
Novartis Pharma AG, CH-4002 Basel, Switzerland
Preclinical Development & Project Management
Novartis Pharma AG, CH-4002 Basel, Switzerland
Head, Research Planning & Operations
Ciba-Geigy Limited, CH-4002 Basel, Switzerland
Ciba-Geigy Limited, CH-4002 Basel, Switzerland
Assistant Professor (tenured July 1, 1978)
Department of Obstetrics & Gynecology and
Professional Societies:
♦ Swiss
♦ American Association for the Advancement of Science ♦ New York Academy of Sciences ♦ The
♦ Swiss Society for Endocrinology ♦ British Endocrine Society ♦ American Physiological Society ♦ Society for the Study of Reproduction
Activities in Ciba-Geigy Limited and Novartis Pharma AG from 1984 to 2001:
Joined Ciba-Geigy as Preclinical Project Leader of Aromatase Inhibitor Project and Deputy Head, Endocrine Research
Head, Endocrine Research and Member, International Project Teams for the development of the Aromatase Inhibitors Formestane (Lentaron®), Fadrozole (Afema®) and Letrozole (Femara®)
Preclinical Project Leader of the 5α-Reductase Inhibitor Project
Preclinical Expert for Registration of Lentaron®, Member of Core Registration Team
Preclinical Expert for the Registration of Estraderm MX and other transdermal systems for hormone replacement therapy. Responsibility for the RIA Lab involved in the measurement of all serum hormones in the clinical development of transdermal systems for HRT.
Appointed International Project Team Leader for Letrozole (Femara®) as well as Head, Research Planning & Operations, Pharma Research Center Basel
Appointed Preclinical Expert and Member Core Registration Team for Letrozole (Femara®)
1996 Femara® registered in France July 1996 1996 Pharmacological
Head, Planning & Administration, Preclinical Development and Project Management Basel Operations, Novartis Pharma AG
Nominated Preclinical Expert for Femara® and Member of Femara International Project Team
Project Manager, Project Year 2000 Pharma Basel
Head, Global Business Continuity Planning
7. Publications
Author of over 50 publications in peer-reviewed journals, several reviews, chapters in books and editor of one book.
Published in Sociology Ethnology Bulletin of Addis Ababa University, Teoderos, a dresser at the new clinic in Turmi, Hamar, Southern Omo, told me in 1989 that his Hamar patients always wanted to be injected whatever complaint they had. This came as news to me and made me wonder why. Whenever I have resided in Hamar, people have come to me in search of foreign medicine ( ferenji däsha ), espec
SECTION VI PRODUCTS OF THE CHEMICAL OR ALLIED INDUSTRIES28. INORGANIC CHEMICALS; ORGANIC OR INORGANIC COMPOUNDS OF PRECIOUS METALS, OF RARE-EARTHMETALS, OF RADIOACTIVE ELEMENTS OR OF ISOTOPES29. ORGANIC CHEMICALS30. PHARMACEUTICAL PRODUCTS31. FERTILIZERS32. TANNING OR DYEING EXTRACTS; TANNINS AND THEIRDERIVATIVES; DYES, PIGMENTS AND OTHER COLOURING MATTER, PAINTS AND VARNISHES:PUTTY AND OTH